Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats

Bu Chin Yu, Chen Kuei Chang, Horng Yih Ou, Kai Chun Cheng, Juei Tang Cheng

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Aims: The role of peroxisome proliferator-activated receptor delta (PPARδ) in the development of cardiomyopathy, which is widely observed in diabetic disorders, is likely because cardiomyocyte-restricted PPARδ deletion causes cardiac hypertrophy. Thus, we investigated the effect of hyperglycaemia-induced oxidative stress on the expression of cardiac PPARδ both in vivo and in vitro. Methods and results: We used male Wistar rats to examine the effect of hyperglycaemia on PPARδ expression in streptozotocin-induced diabetic rats, primary neonatal rat cardiomyocytes, and H9c2 embryonic rat cardiomyocytes. PPARδ mRNA (messenger ribonucleic acid) and protein levels were measured using northern and western blotting, respectively. The lipid deposition within the heart section was assessed by oil red O staining. The formation of reactive oxygen species (ROS) and changes in morphology, protein synthesis, and α-actinin content in hyperglycaemic cells were also examined. Inhibitors of ROS production or mitogen-activated protein kinase (MAPK) activation were employed to investigate the possible mechanisms. Cardiomyopathy induced in streptozotocin-diabetic rats was associated with a marked decrease in cardiac PPARδ expression. Also, ROS production, cell size, and protein synthesis were increased while PPARδ expression was reduced in cells exposed to hyperglycaemia in vitro. However, these glucose-induced changes were abolished in the presence of tiron or PD98059 (MEK/ERK inhibitor). Conclusion: Our results suggest that inhibitors of ROS production or MAPK activation are involved in reduction of cardiac PPARδ expression in response to hyperglycaemia.

Original languageEnglish
Pages (from-to)78-87
Number of pages10
JournalCardiovascular Research
Volume80
Issue number1
DOIs
Publication statusPublished - Oct 2008

Fingerprint

PPAR delta
Streptozocin
Cardiomyopathies
Hyperglycemia
Reactive Oxygen Species
Cardiac Myocytes
Mitogen-Activated Protein Kinases
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt
Actinin
Proteins
Mitogen-Activated Protein Kinase Kinases
Cardiomegaly
Cell Size
Northern Blotting
Wistar Rats
Oxidative Stress
Western Blotting
RNA
Staining and Labeling
Lipids

Keywords

  • Cardiomyopathy
  • Cell culture
  • Diabetes
  • Gene expression
  • Oxygen radicals

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats. / Yu, Bu Chin; Chang, Chen Kuei; Ou, Horng Yih; Cheng, Kai Chun; Cheng, Juei Tang.

In: Cardiovascular Research, Vol. 80, No. 1, 10.2008, p. 78-87.

Research output: Contribution to journalArticle

@article{f036af29d14045e78fe683b1bb7f9eec,
title = "Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats",
abstract = "Aims: The role of peroxisome proliferator-activated receptor delta (PPARδ) in the development of cardiomyopathy, which is widely observed in diabetic disorders, is likely because cardiomyocyte-restricted PPARδ deletion causes cardiac hypertrophy. Thus, we investigated the effect of hyperglycaemia-induced oxidative stress on the expression of cardiac PPARδ both in vivo and in vitro. Methods and results: We used male Wistar rats to examine the effect of hyperglycaemia on PPARδ expression in streptozotocin-induced diabetic rats, primary neonatal rat cardiomyocytes, and H9c2 embryonic rat cardiomyocytes. PPARδ mRNA (messenger ribonucleic acid) and protein levels were measured using northern and western blotting, respectively. The lipid deposition within the heart section was assessed by oil red O staining. The formation of reactive oxygen species (ROS) and changes in morphology, protein synthesis, and α-actinin content in hyperglycaemic cells were also examined. Inhibitors of ROS production or mitogen-activated protein kinase (MAPK) activation were employed to investigate the possible mechanisms. Cardiomyopathy induced in streptozotocin-diabetic rats was associated with a marked decrease in cardiac PPARδ expression. Also, ROS production, cell size, and protein synthesis were increased while PPARδ expression was reduced in cells exposed to hyperglycaemia in vitro. However, these glucose-induced changes were abolished in the presence of tiron or PD98059 (MEK/ERK inhibitor). Conclusion: Our results suggest that inhibitors of ROS production or MAPK activation are involved in reduction of cardiac PPARδ expression in response to hyperglycaemia.",
keywords = "Cardiomyopathy, Cell culture, Diabetes, Gene expression, Oxygen radicals",
author = "Yu, {Bu Chin} and Chang, {Chen Kuei} and Ou, {Horng Yih} and Cheng, {Kai Chun} and Cheng, {Juei Tang}",
year = "2008",
month = "10",
doi = "10.1093/cvr/cvn172",
language = "English",
volume = "80",
pages = "78--87",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats

AU - Yu, Bu Chin

AU - Chang, Chen Kuei

AU - Ou, Horng Yih

AU - Cheng, Kai Chun

AU - Cheng, Juei Tang

PY - 2008/10

Y1 - 2008/10

N2 - Aims: The role of peroxisome proliferator-activated receptor delta (PPARδ) in the development of cardiomyopathy, which is widely observed in diabetic disorders, is likely because cardiomyocyte-restricted PPARδ deletion causes cardiac hypertrophy. Thus, we investigated the effect of hyperglycaemia-induced oxidative stress on the expression of cardiac PPARδ both in vivo and in vitro. Methods and results: We used male Wistar rats to examine the effect of hyperglycaemia on PPARδ expression in streptozotocin-induced diabetic rats, primary neonatal rat cardiomyocytes, and H9c2 embryonic rat cardiomyocytes. PPARδ mRNA (messenger ribonucleic acid) and protein levels were measured using northern and western blotting, respectively. The lipid deposition within the heart section was assessed by oil red O staining. The formation of reactive oxygen species (ROS) and changes in morphology, protein synthesis, and α-actinin content in hyperglycaemic cells were also examined. Inhibitors of ROS production or mitogen-activated protein kinase (MAPK) activation were employed to investigate the possible mechanisms. Cardiomyopathy induced in streptozotocin-diabetic rats was associated with a marked decrease in cardiac PPARδ expression. Also, ROS production, cell size, and protein synthesis were increased while PPARδ expression was reduced in cells exposed to hyperglycaemia in vitro. However, these glucose-induced changes were abolished in the presence of tiron or PD98059 (MEK/ERK inhibitor). Conclusion: Our results suggest that inhibitors of ROS production or MAPK activation are involved in reduction of cardiac PPARδ expression in response to hyperglycaemia.

AB - Aims: The role of peroxisome proliferator-activated receptor delta (PPARδ) in the development of cardiomyopathy, which is widely observed in diabetic disorders, is likely because cardiomyocyte-restricted PPARδ deletion causes cardiac hypertrophy. Thus, we investigated the effect of hyperglycaemia-induced oxidative stress on the expression of cardiac PPARδ both in vivo and in vitro. Methods and results: We used male Wistar rats to examine the effect of hyperglycaemia on PPARδ expression in streptozotocin-induced diabetic rats, primary neonatal rat cardiomyocytes, and H9c2 embryonic rat cardiomyocytes. PPARδ mRNA (messenger ribonucleic acid) and protein levels were measured using northern and western blotting, respectively. The lipid deposition within the heart section was assessed by oil red O staining. The formation of reactive oxygen species (ROS) and changes in morphology, protein synthesis, and α-actinin content in hyperglycaemic cells were also examined. Inhibitors of ROS production or mitogen-activated protein kinase (MAPK) activation were employed to investigate the possible mechanisms. Cardiomyopathy induced in streptozotocin-diabetic rats was associated with a marked decrease in cardiac PPARδ expression. Also, ROS production, cell size, and protein synthesis were increased while PPARδ expression was reduced in cells exposed to hyperglycaemia in vitro. However, these glucose-induced changes were abolished in the presence of tiron or PD98059 (MEK/ERK inhibitor). Conclusion: Our results suggest that inhibitors of ROS production or MAPK activation are involved in reduction of cardiac PPARδ expression in response to hyperglycaemia.

KW - Cardiomyopathy

KW - Cell culture

KW - Diabetes

KW - Gene expression

KW - Oxygen radicals

UR - http://www.scopus.com/inward/record.url?scp=51749114921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51749114921&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvn172

DO - 10.1093/cvr/cvn172

M3 - Article

C2 - 18573863

AN - SCOPUS:51749114921

VL - 80

SP - 78

EP - 87

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 1

ER -